Statistics about Health, Pharma & Medtech in United States
Statistics
- Sonnet Biotherapeutics Holdings, Inc. liabilities 2021-2025
- Adial Pharmaceuticals, Inc. total assets 2021-2025
- Eli Lilly total assets 2021-2025
- Processa Pharmaceuticals, Inc. total assets 2021-2025
- Tango Therapeutics, Inc. liabilities 2021-2025
- Nanomix Corp liabilities 2018-2022
- Cannagistics liabilities 2017-2021
- Respirerx Pharmaceuticals total assets 2018-2022
- Titan Pharmaceuticals total assets 2020-2024
- Acurx Pharmaceuticals total assets 2021-2025
- Psychemedics liabilities 2020-2024
- Stem Holdings, Inc. liabilities 2019-2023
- Nanoviricides total assets 2021-2025
- Northwest Biotherapeutics liabilities 2021-2025
- Kodiak Sciences total assets 2021-2025
- Celldex Therapeutics liabilities 2021-2025
- One World Products, Inc. total assets 2020-2024
- Axsome Therapeutics total assets 2021-2025
- Amicus Therapeutics liabilities 2021-2025
- Sellas Life Sciences total assets 2021-2025
- Iovance Biotherapeutics, Inc. liabilities 2021-2025
- Lineage Cell Therapeutics liabilities 2021-2025
- Ikena Oncology liabilities 2021-2025
- Repligen liabilities 2021-2025
- Otonomy liabilities 2017-2021
- Meridian Bioscience Inc total assets 2018-2022
- Seres Therapeutics liabilities 2021-2025
- Protokinetix liabilities 2016-2020
- Silo Pharma, Inc. liabilities 2021-2025
- Adhera Therapeutics, Inc. liabilities 2018-2022
- Ovid Therapeutics liabilities 2021-2025
- Bio-Path Holdings liabilities 2021-2025
- Crinetics Pharmaceuticals liabilities 2021-2025
- Kalvista Pharmaceuticals total assets 2021-2025
- RadNet total assets 2021-2025
- VivoSim Labs, INC. total assets 2020-2024
- Anixa Biosciences total assets 2021-2025
- Eyenovia total assets 2021-2025
- 4D Molecular Therapeutics liabilities 2021-2025
- Trevi Therapeutics total assets 2021-2025
- Spero Therapeutics liabilities 2021-2025
- Optinose liabilities 2020-2024
- Editas Medicine total assets 2021-2025
- Summit Therapeutics total assets 2021-2025
- Nextcure liabilities 2021-2025
- Iteos Therapeutics liabilities 2020-2024
- Aytu Bioscience liabilities 2019-2023
- Exagen Diagnostics total assets 2021-2025
- Quince Therapeutics, Inc. liabilities 2021-2025
- Aerovate Therapeutics total assets 2021-2025
- Iveric Bio, Inc. total assets 2018-2022
- Serina Therapeutics liabilities 2021-2025
- Avrobio liabilities 2021-2025
- Burzynski Research Institute liabilities 2020-2024
- Humanigen, Inc liabilities 2018-2022
- Societal Cdmo liabilities 2019-2023
- Tauriga Sciences total assets 2016-2020
- Opus Genetics, Inc. liabilities 2021-2025
- Omeros total assets 2021-2025
- Aprea Therapeutics liabilities 2018-2022
- Igm Biosciences liabilities 2020-2024
- Revelation Biosciences, Inc. liabilities 2021-2025
- Tenax Therapeutics liabilities 2021-2025
- Harrow liabilities 2021-2025
- Alpha Teknova liabilities 2021-2025
- Alpine Immune Sciences liabilities 2019-2023
- Nkgen Biotech, Inc. liabilities 2021-2024
- Scholar Rock Holding total assets 2021-2025
- Mustang Bio liabilities 2021-2025
- Eledon Pharmaceuticals liabilities 2021-2025
- Exicure total assets 2021-2025
- Innovation1 Biotech total assets 2019-2023
- Elevation Oncology liabilities 2020-2024
- 9 Meters Biopharma liabilities 2018-2022
- American Bio Medica liabilities 2018-2022
- Cannabis Global, Inc. liabilities 2017-2021
- Oyster Point Pharma, Inc. total assets 2018-2021
- Novabay Pharmaceuticals total assets 2021-2025
- Invitae total assets 2018-2022
- Olema Pharmaceuticals liabilities 2021-2025
- Axcella Health liabilities 2018-2022
- Fuss Brands Corp. liabilities 2020-2024
- Adial Pharmaceuticals, Inc. liabilities 2021-2025
- Artelo Biosciences total assets 2021-2025
- Revolution Medicines liabilities 2021-2025
- Cti Biopharma Corp liabilities 2018-2022
- Phasebio Pharmaceuticals liabilities 2017-2021
- Nrx Pharmaceuticals liabilities 2021-2025
- Eom Pharmaceutical Holdings total assets 2013-2017
- 2Seventy Bio, Inc. total assets 2020-2024
- Athenex, Inc. total assets 2018-2022
- Sigilon Therapeutics total assets 2020-2022
- Pepgen Inc. total assets 2021-2025
- Chimerix liabilities 2020-2024
- Hero Technologies liabilities 2014-2022
- Processa Pharmaceuticals, Inc. liabilities 2021-2025
- Lipella Pharmaceuticals liabilities 2021-2024
- Myriad Genetics total assets 2021-2025
- Protagonist Therapeutics total assets 2021-2025
- Natural Alternatives liabilities 2021-2025